Mitomycin C 13C,15N2

[13C,15N2]-Mitomycin C is a modified form of the natural antibiotic and antitumor agent, Mitomycin C. This compound is labeled with isotopes of carbon and nitrogen, which can be used to track its behavior and interactions in biological systems. Mitomycin C works by inhibiting DNA synthesis and replication, which ultimately leads to cell death. It is commonly used in chemotherapy to treat various types of cancer, including bladder, breast, and lung cancer. [13C,15N2]-Mitomycin C can be used in research to study the mechanism of action of Mitomycin C and to investigate the pharmacokinetics and pharmacodynamics of the drug in vivo. The isotopic labeling of [13C,15N2]-Mitomycin C allows for precise measurements of its absorption, distribution, metabolism, and excretion in cells and tissues. This information can be critical for optimizing the dosing and efficacy of Mitomycin C in cancer treatment. Additionally, the labeled compound can be used in imaging techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry to study its interactions with DNA and other biomolecules. Overall, [13C,15N2]-Mitomycin C is a valuable tool in cancer research and drug development, providing insights into the mechanisms of action and pharmacokinetics of Mitomycin C and potentially leading to improved treatment options for cancer patients.